Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash-to-Debt 0.23
CHE's Cash-to-Debt is ranked lower than
71% of the 267 Companies
in the Global Medical Care industry.

( Industry Median: 0.37 vs. CHE: 0.23 )
Ranked among companies with meaningful Cash-to-Debt only.
CHE' s Cash-to-Debt Range Over the Past 10 Years
Min: 0  Med: 0.16 Max: 2.78
Current: 0.23
0
2.78
Equity-to-Asset 0.53
CHE's Equity-to-Asset is ranked higher than
52% of the 261 Companies
in the Global Medical Care industry.

( Industry Median: 0.50 vs. CHE: 0.53 )
Ranked among companies with meaningful Equity-to-Asset only.
CHE' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.31  Med: 0.5 Max: 0.61
Current: 0.53
0.31
0.61
Debt-to-Equity 0.17
CHE's Debt-to-Equity is ranked higher than
73% of the 193 Companies
in the Global Medical Care industry.

( Industry Median: 0.63 vs. CHE: 0.17 )
Ranked among companies with meaningful Debt-to-Equity only.
CHE' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.13  Med: 0.41 Max: 1.17
Current: 0.17
0.13
1.17
Debt-to-EBITDA 0.55
CHE's Debt-to-EBITDA is ranked higher than
81% of the 197 Companies
in the Global Medical Care industry.

( Industry Median: 2.82 vs. CHE: 0.55 )
Ranked among companies with meaningful Debt-to-EBITDA only.
CHE' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.42  Med: 0.91 Max: 1.62
Current: 0.55
0.42
1.62
Interest Coverage 27.08
CHE's Interest Coverage is ranked higher than
68% of the 224 Companies
in the Global Medical Care industry.

( Industry Median: 7.55 vs. CHE: 27.08 )
Ranked among companies with meaningful Interest Coverage only.
CHE' s Interest Coverage Range Over the Past 10 Years
Min: 8.87  Med: 11.02 Max: 50.61
Current: 27.08
8.87
50.61
Piotroski F-Score: 6
Altman Z-Score: 8.94
Beneish M-Score: -3.17
WACC vs ROIC
11.89%
12.90%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating Margin % 6.68
CHE's Operating Margin % is ranked lower than
55% of the 267 Companies
in the Global Medical Care industry.

( Industry Median: 7.34 vs. CHE: 6.68 )
Ranked among companies with meaningful Operating Margin % only.
CHE' s Operating Margin % Range Over the Past 10 Years
Min: 6.68  Med: 11.28 Max: 11.95
Current: 6.68
6.68
11.95
Net Margin % 4.62
CHE's Net Margin % is ranked higher than
50% of the 267 Companies
in the Global Medical Care industry.

( Industry Median: 4.16 vs. CHE: 4.62 )
Ranked among companies with meaningful Net Margin % only.
CHE' s Net Margin % Range Over the Past 10 Years
Min: 4.62  Med: 6.29 Max: 7.14
Current: 4.62
4.62
7.14
ROE % 15.52
CHE's ROE % is ranked higher than
68% of the 250 Companies
in the Global Medical Care industry.

( Industry Median: 9.23 vs. CHE: 15.52 )
Ranked among companies with meaningful ROE % only.
CHE' s ROE % Range Over the Past 10 Years
Min: 15.52  Med: 18.66 Max: 22.86
Current: 15.52
15.52
22.86
ROA % 8.59
CHE's ROA % is ranked higher than
73% of the 269 Companies
in the Global Medical Care industry.

( Industry Median: 3.45 vs. CHE: 8.59 )
Ranked among companies with meaningful ROA % only.
CHE' s ROA % Range Over the Past 10 Years
Min: 8.18  Med: 10.25 Max: 12.88
Current: 8.59
8.18
12.88
ROC (Joel Greenblatt) % 89.40
CHE's ROC (Joel Greenblatt) % is ranked higher than
86% of the 269 Companies
in the Global Medical Care industry.

( Industry Median: 14.51 vs. CHE: 89.40 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
CHE' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 89.4  Med: 170.4 Max: 190.39
Current: 89.4
89.4
190.39
3-Year Revenue Growth Rate 7.30
CHE's 3-Year Revenue Growth Rate is ranked lower than
51% of the 209 Companies
in the Global Medical Care industry.

( Industry Median: 7.70 vs. CHE: 7.30 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
CHE' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -19.5  Med: 8.2 Max: 42.9
Current: 7.3
-19.5
42.9
3-Year EBITDA Growth Rate 12.30
CHE's 3-Year EBITDA Growth Rate is ranked higher than
63% of the 186 Companies
in the Global Medical Care industry.

( Industry Median: 7.10 vs. CHE: 12.30 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
CHE' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -31.4  Med: 8.1 Max: 52.3
Current: 12.3
-31.4
52.3
3-Year EPS without NRI Growth Rate 15.90
CHE's 3-Year EPS without NRI Growth Rate is ranked higher than
66% of the 163 Companies
in the Global Medical Care industry.

( Industry Median: 7.00 vs. CHE: 15.90 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
CHE' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -27.4  Med: 11.1 Max: 59.5
Current: 15.9
-27.4
59.5
GuruFocus has detected 5 Warning Signs with Chemed Corp CHE.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» CHE's 30-Y Financials

Financials (Next Earnings Date: 2018-02-15)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q4 2016

CHE Guru Trades in Q4 2016

Mario Gabelli 626,491 sh (-1.43%)
Ken Fisher 540,570 sh (-1.59%)
Keeley Asset Management Corp 15,035 sh (-5.94%)
Chuck Royce 40,888 sh (-27.12%)
Jeremy Grantham 50,712 sh (-34.78%)
Jim Simons 51,900 sh (-45.25%)
Joel Greenblatt 35,525 sh (-59.55%)
» More
Q1 2017

CHE Guru Trades in Q1 2017

Mario Gabelli 596,500 sh (-4.79%)
Ken Fisher 512,624 sh (-5.17%)
Joel Greenblatt 27,512 sh (-22.56%)
Jeremy Grantham 34,007 sh (-32.94%)
Chuck Royce 20,852 sh (-49.00%)
Jim Simons 20,200 sh (-61.08%)
» More
Q2 2017

CHE Guru Trades in Q2 2017

Caxton Associates 2,732 sh (New)
Jim Simons 70,400 sh (+248.51%)
Joel Greenblatt 31,681 sh (+15.15%)
Chuck Royce 20,852 sh (unchged)
Ken Fisher 500,692 sh (-2.33%)
Mario Gabelli 556,484 sh (-6.71%)
Jeremy Grantham 25,807 sh (-24.11%)
» More
Q3 2017

CHE Guru Trades in Q3 2017

Jim Simons 106,300 sh (+50.99%)
Caxton Associates 2,732 sh (unchged)
Ken Fisher 496,254 sh (-0.89%)
Chuck Royce 20,008 sh (-4.05%)
Mario Gabelli 527,204 sh (-5.26%)
Jeremy Grantham 16,807 sh (-34.87%)
Joel Greenblatt 18,034 sh (-43.08%)
» More
» Details

Insider Trades

Latest Guru Trades with CHE

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Mario Gabelli 2017-09-30 Reduce -5.26%0.04%$187.48 - $206.31 $ 238.1621%527,204
Ken Fisher 2017-09-30 Reduce -0.89%$187.48 - $206.31 $ 238.1621%496,254
Joel Greenblatt 2017-09-30 Reduce -43.08%0.04%$187.48 - $206.31 $ 238.1621%18,034
Mario Gabelli 2017-06-30 Reduce -6.71%0.05%$181.6 - $211.35 $ 238.1620%556,484
Ken Fisher 2017-06-30 Reduce -2.33%$181.6 - $211.35 $ 238.1620%500,692
Joel Greenblatt 2017-06-30 Add 15.15%0.01%$181.6 - $211.35 $ 238.1620%31,681
Mario Gabelli 2017-03-31 Reduce -4.79%0.03%$162.11 - $186.79 $ 238.1637%596,500
Ken Fisher 2017-03-31 Reduce -5.17%0.01%$162.11 - $186.79 $ 238.1637%512,624
Joel Greenblatt 2017-03-31 Reduce -22.56%0.02%$162.11 - $186.79 $ 238.1637%27,512
Mario Gabelli 2016-12-31 Reduce -1.43%0.01%$133.29 - $161.01 $ 238.1662%626,491
Ken Fisher 2016-12-31 Reduce -1.59%$133.29 - $161.01 $ 238.1662%540,570
Joel Greenblatt 2016-12-31 Reduce -59.55%0.1%$133.29 - $161.01 $ 238.1662%35,525
Keeley Asset Management Corp 2016-12-31 Reduce -5.94%0.01%$133.29 - $161.01 $ 238.1662%15,035
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Providers » Medical Care    NAICS: 621610    SIC: 8082
Compare:NYSE:MD, NAS:ACHC, NYSE:HLS, ASX:HSO, XSGO:BANMEDICA, NYSE:SEM, BKK:BH, JSE:NTC, XTER:RHK, NSE:APOLLOHOSP, NYSE:EVHC, JSE:LHC, SAU:4002, NYSE:AMN, ISX:MIKA, NAS:LPNT, OSTO:ATT, NAS:TVTY, HKSE:01515, NAS:AMED » details
Traded in other countries:CXM.Germany,
Headquarter Location:USA
Chemed Corp through its subsidiaries, provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers and also plumbing and drain cleaning services.

Chemed Corp through its subsidiaries, provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers and also plumbing and drain cleaning services.

Ratios

vs
industry
vs
history
PE Ratio 52.91
CHE's PE Ratio is ranked lower than
80% of the 200 Companies
in the Global Medical Care industry.

( Industry Median: 26.57 vs. CHE: 52.91 )
Ranked among companies with meaningful PE Ratio only.
CHE' s PE Ratio Range Over the Past 10 Years
Min: 10.72  Med: 18.27 Max: 53.47
Current: 52.91
10.72
53.47
Forward PE Ratio 27.10
CHE's Forward PE Ratio is ranked lower than
66% of the 58 Companies
in the Global Medical Care industry.

( Industry Median: 19.88 vs. CHE: 27.10 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 52.91
CHE's PE Ratio without NRI is ranked lower than
80% of the 196 Companies
in the Global Medical Care industry.

( Industry Median: 26.50 vs. CHE: 52.91 )
Ranked among companies with meaningful PE Ratio without NRI only.
CHE' s PE Ratio without NRI Range Over the Past 10 Years
Min: 10.75  Med: 17.93 Max: 53.47
Current: 52.91
10.75
53.47
Price-to-Owner-Earnings 110.70
CHE's Price-to-Owner-Earnings is ranked lower than
99% of the 106 Companies
in the Global Medical Care industry.

( Industry Median: 26.22 vs. CHE: 110.70 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
CHE' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 7.86  Med: 18.77 Max: 603.86
Current: 110.7
7.86
603.86
PB Ratio 7.99
CHE's PB Ratio is ranked lower than
90% of the 251 Companies
in the Global Medical Care industry.

( Industry Median: 2.62 vs. CHE: 7.99 )
Ranked among companies with meaningful PB Ratio only.
CHE' s PB Ratio Range Over the Past 10 Years
Min: 1.89  Med: 2.98 Max: 8.06
Current: 7.99
1.89
8.06
PS Ratio 2.40
CHE's PS Ratio is ranked lower than
58% of the 259 Companies
in the Global Medical Care industry.

( Industry Median: 1.70 vs. CHE: 2.40 )
Ranked among companies with meaningful PS Ratio only.
CHE' s PS Ratio Range Over the Past 10 Years
Min: 0.67  Med: 1.09 Max: 2.43
Current: 2.4
0.67
2.43
Price-to-Free-Cash-Flow 28.83
CHE's Price-to-Free-Cash-Flow is ranked lower than
63% of the 124 Companies
in the Global Medical Care industry.

( Industry Median: 22.48 vs. CHE: 28.83 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
CHE' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 7.1  Med: 14.32 Max: 81.38
Current: 28.83
7.1
81.38
Price-to-Operating-Cash-Flow 19.96
CHE's Price-to-Operating-Cash-Flow is ranked lower than
67% of the 179 Companies
in the Global Medical Care industry.

( Industry Median: 14.62 vs. CHE: 19.96 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
CHE' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 5.92  Med: 10.77 Max: 29.66
Current: 19.96
5.92
29.66
EV-to-EBIT 33.56
CHE's EV-to-EBIT is ranked lower than
74% of the 209 Companies
in the Global Medical Care industry.

( Industry Median: 20.85 vs. CHE: 33.56 )
Ranked among companies with meaningful EV-to-EBIT only.
CHE' s EV-to-EBIT Range Over the Past 10 Years
Min: 7.1  Med: 10.7 Max: 34.6
Current: 33.56
7.1
34.6
EV-to-EBITDA 25.64
CHE's EV-to-EBITDA is ranked lower than
74% of the 227 Companies
in the Global Medical Care industry.

( Industry Median: 15.17 vs. CHE: 25.64 )
Ranked among companies with meaningful EV-to-EBITDA only.
CHE' s EV-to-EBITDA Range Over the Past 10 Years
Min: 5.9  Med: 8.8 Max: 26.5
Current: 25.64
5.9
26.5
EV-to-Revenue 2.36
CHE's EV-to-Revenue is ranked higher than
52% of the 265 Companies
in the Global Medical Care industry.

( Industry Median: 2.18 vs. CHE: 2.36 )
Ranked among companies with meaningful EV-to-Revenue only.
CHE' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.8  Med: 1.1 Max: 2.4
Current: 2.36
0.8
2.4
PEG Ratio 6.13
CHE's PEG Ratio is ranked lower than
80% of the 94 Companies
in the Global Medical Care industry.

( Industry Median: 3.00 vs. CHE: 6.13 )
Ranked among companies with meaningful PEG Ratio only.
CHE' s PEG Ratio Range Over the Past 10 Years
Min: 0.3  Med: 1.33 Max: 13.42
Current: 6.13
0.3
13.42
Shiller PE Ratio 50.06
CHE's Shiller PE Ratio is ranked lower than
65% of the 55 Companies
in the Global Medical Care industry.

( Industry Median: 27.79 vs. CHE: 50.06 )
Ranked among companies with meaningful Shiller PE Ratio only.
CHE' s Shiller PE Ratio Range Over the Past 10 Years
Min: 22.74  Med: 34.37 Max: 76.53
Current: 50.06
22.74
76.53
Current Ratio 0.50
CHE's Current Ratio is ranked lower than
88% of the 253 Companies
in the Global Medical Care industry.

( Industry Median: 1.41 vs. CHE: 0.50 )
Ranked among companies with meaningful Current Ratio only.
CHE' s Current Ratio Range Over the Past 10 Years
Min: 0.5  Med: 1.25 Max: 2.32
Current: 0.5
0.5
2.32
Quick Ratio 0.48
CHE's Quick Ratio is ranked lower than
85% of the 253 Companies
in the Global Medical Care industry.

( Industry Median: 1.31 vs. CHE: 0.48 )
Ranked among companies with meaningful Quick Ratio only.
CHE' s Quick Ratio Range Over the Past 10 Years
Min: 0.48  Med: 1.07 Max: 2.06
Current: 0.48
0.48
2.06
Days Inventory 1.83
CHE's Days Inventory is ranked higher than
92% of the 199 Companies
in the Global Medical Care industry.

( Industry Median: 16.86 vs. CHE: 1.83 )
Ranked among companies with meaningful Days Inventory only.
CHE' s Days Inventory Range Over the Past 10 Years
Min: 1.83  Med: 2.93 Max: 3.3
Current: 1.83
1.83
3.3
Days Sales Outstanding 20.34
CHE's Days Sales Outstanding is ranked higher than
67% of the 220 Companies
in the Global Medical Care industry.

( Industry Median: 41.26 vs. CHE: 20.34 )
Ranked among companies with meaningful Days Sales Outstanding only.
CHE' s Days Sales Outstanding Range Over the Past 10 Years
Min: 16.39  Med: 27.85 Max: 33.57
Current: 20.34
16.39
33.57
Days Payable 11.15
CHE's Days Payable is ranked lower than
81% of the 159 Companies
in the Global Medical Care industry.

( Industry Median: 51.14 vs. CHE: 11.15 )
Ranked among companies with meaningful Days Payable only.
CHE' s Days Payable Range Over the Past 10 Years
Min: 11.15  Med: 17.63 Max: 23.78
Current: 11.15
11.15
23.78

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 0.45
CHE's Dividend Yield % is ranked lower than
88% of the 250 Companies
in the Global Medical Care industry.

( Industry Median: 1.63 vs. CHE: 0.45 )
Ranked among companies with meaningful Dividend Yield % only.
CHE' s Dividend Yield % Range Over the Past 10 Years
Min: 0.35  Med: 0.72 Max: 1.2
Current: 0.45
0.35
1.2
Dividend Payout Ratio 0.23
CHE's Dividend Payout Ratio is ranked higher than
90% of the 151 Companies
in the Global Medical Care industry.

( Industry Median: 9999.00 vs. CHE: 0.23 )
Ranked among companies with meaningful Dividend Payout Ratio only.
CHE' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.08  Med: 0.15 Max: 0.23
Current: 0.23
0.08
0.23
3-Year Dividend Growth Rate 9.60
CHE's 3-Year Dividend Growth Rate is ranked higher than
50% of the 82 Companies
in the Global Medical Care industry.

( Industry Median: 9.60 vs. CHE: 9.60 )
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
CHE' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: -42.4  Med: 2.2 Max: 35.7
Current: 9.6
-42.4
35.7
Forward Dividend Yield % 0.47
CHE's Forward Dividend Yield % is ranked lower than
90% of the 240 Companies
in the Global Medical Care industry.

( Industry Median: 1.91 vs. CHE: 0.47 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 0.75
CHE's 5-Year Yield-on-Cost % is ranked lower than
83% of the 326 Companies
in the Global Medical Care industry.

( Industry Median: 2.24 vs. CHE: 0.75 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
CHE' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.58  Med: 1.2 Max: 1.99
Current: 0.75
0.58
1.99
3-Year Average Share Buyback Ratio 2.70
CHE's 3-Year Average Share Buyback Ratio is ranked higher than
93% of the 159 Companies
in the Global Medical Care industry.

( Industry Median: -2.50 vs. CHE: 2.70 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
CHE' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -9.8  Med: 1.3 Max: 6.4
Current: 2.7
-9.8
6.4

Valuation & Return

vs
industry
vs
history
Price-to-Intrinsic-Value-Projected-FCF 2.53
CHE's Price-to-Intrinsic-Value-Projected-FCF is ranked lower than
52% of the 103 Companies
in the Global Medical Care industry.

( Industry Median: 1.98 vs. CHE: 2.53 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
CHE' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.59  Med: 1.25 Max: 2.56
Current: 2.53
0.59
2.56
Price-to-Intrinsic-Value-DCF (Earnings Based) 3.28
CHE's Price-to-Intrinsic-Value-DCF (Earnings Based) is ranked lower than
86% of the 36 Companies
in the Global Medical Care industry.

( Industry Median: 1.59 vs. CHE: 3.28 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
CHE' s Price-to-Intrinsic-Value-DCF (Earnings Based) Range Over the Past 10 Years
Min: 0.52  Med: 1.16 Max: 3.17
Current: 3.28
0.52
3.17
Price-to-Median-PS-Value 2.20
CHE's Price-to-Median-PS-Value is ranked lower than
89% of the 232 Companies
in the Global Medical Care industry.

( Industry Median: 1.03 vs. CHE: 2.20 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
CHE' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.29  Med: 0.84 Max: 2.22
Current: 2.2
0.29
2.22
Earnings Yield (Greenblatt) % 2.96
CHE's Earnings Yield (Greenblatt) % is ranked lower than
58% of the 269 Companies
in the Global Medical Care industry.

( Industry Median: 3.79 vs. CHE: 2.96 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
CHE' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 2.9  Med: 9.4 Max: 14.1
Current: 2.96
2.9
14.1
Forward Rate of Return (Yacktman) % 6.76
CHE's Forward Rate of Return (Yacktman) % is ranked lower than
53% of the 128 Companies
in the Global Medical Care industry.

( Industry Median: 8.93 vs. CHE: 6.76 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
CHE' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 6.7  Med: 18.3 Max: 57.5
Current: 6.76
6.7
57.5

More Statistics

Revenue (TTM) (Mil) $1,641.84
EPS (TTM) $ 4.50
Beta1.63
Short Percentage of Float12.46%
52-Week Range $145.35 - 241.57
Shares Outstanding (Mil)15.97

Analyst Estimate

Dec17 Dec18
Revenue (Mil $) 1,660 1,691
EPS ($) 8.37 8.79
EPS without NRI ($) 8.37 8.79
EPS Growth Rate
(Future 3Y To 5Y Estimate)
10.00%
Dividends per Share ($)

Piotroski F-Score Details

Piotroski F-Score: 66
Positive ROAY
Positive CFROAY
Higher ROA yoyN
CFROA > ROAY
Lower Leverage yoyY
Higher Current Ratio yoyN
Less Shares Outstanding yoyN
Higher Gross Margin yoyY
Higher Asset Turnover yoyY

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}